GlassScriptPhysician profile
Xiaoran Zhang
NPI 1437508256
$6,363.23
in general payments reported to CMS, 2019-2025
8 companies · $4,269 in 2025
The $4,269 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $212 · 2023: $477 · 2024: $1,405 · 2025: $4,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Food and Beverage: $2,009 · Travel and Lodging: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Food and Beverage | $2,009.42 |
| Travel and Lodging | $1,391.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $5,284.77 | 2024-2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Nuvasive, INC. | $477.20 | 2023 | Alif, Xlif, Modulus |
| Stryker Corporation | $203.70 | 2022-2024 | Core, Sonopet Iq |
| Globus Medical, INC. | $202.76 | 2024-2025 | Xlif, Altera |
| Novocure INC. | $149.49 | 2025 | |
| Abbott Laboratories | $24.41 | 2022 | |
| Providence Medical Technology, INC. | $20.90 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaoran Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.